Streetbeat News

Regulatory

CPRX

Catalyst Pharmaceuticals' FIRDAPSE has been approved in Japan for treating Lambert-Eaton Myasthenic Syndrome (LEMS), marking a significant milestone for the company and its sub-licensee, DyDo Pharma. This approval expands FIRDAPSE's reach beyond the U.S., where it is already a leading therapy for LEMS.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:08 am

LLY

Eli Lilly announced that Japan has approved its drug Kisunla (Donanemab-azbt) for early symptomatic Alzheimer's disease. The approval was based on data from the TRAILBLAZER-ALZ 2 Phase 3 clinical study.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:07 am

NVO

Novo Nordisk's CEO announced that their drug Ozempic will be eligible for U.S. price negotiations within a year, aligning with expectations for 2027. The Senate will scrutinize the high prices of Ozempic and Wegovy, amid concerns over counterfeit versions.

Portfolio Pulse from Benzinga Neuro

September 24, 2024 | 9:48 am

FXI

SPY

The Governor of China's Central Bank announced that the Medium Term Lending Rate and Lending Prime Rate will be reduced further. This move is likely aimed at stimulating economic growth by making borrowing cheaper.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 9:26 am

FXI

SPY

China's Central Bank Governor announced a reduction in mortgage rates for existing homes to support the steady recovery of prices in the economy. This move is part of broader efforts to shore up the real estate market.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 9:25 am

META

TikTok has permanently banned accounts linked to Russian state media outlets RT and Sputnik for violating community guidelines. This move is part of a broader crackdown on Russian state media by major social media platforms, including Meta's recent global ban on these outlets.

Portfolio Pulse from Benzinga Neuro

September 24, 2024 | 8:52 am

META

Meta Platforms Inc. is set to introduce an AI chatbot capable of mimicking celebrity voices, including Judi Dench and John Cena, at its Connect conference. This move follows agreements with several actors and aims to enhance user experience across Meta's apps. The development comes after a controversy involving OpenAI and Scarlett Johansson, highlighting the need for regulations in AI voice replication.

Portfolio Pulse from Ananya Gairola

September 24, 2024 | 8:51 am

V

Visa Inc. is reportedly facing a DOJ antitrust lawsuit for allegedly monopolizing the US debit card market. The DOJ accuses Visa of anti-competitive practices, including exclusivity agreements, following a long investigation. This lawsuit is part of a broader DOJ crackdown on monopolistic activities.

Portfolio Pulse from Kaustubh Bagalkote

September 24, 2024 | 8:41 am

TAK

Takeda has received approval in Japan for its FRUZAQLA Capsules, a treatment for advanced colorectal cancer. The approval is based on successful results from the FRESCO-2 trial, which showed efficacy and a manageable safety profile. This approval marks a significant advancement in treatment options for metastatic colorectal cancer.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 7:22 am

CEG

MSFT

Pennsylvania Governor Josh Shapiro is urging regulators to expedite the integration of the Three Mile Island nuclear reactor into the power grid, enabling Microsoft to use its power by 2028. Microsoft has a 20-year power purchase agreement with Constellation Energy, which owns the reactor. This move aligns with Microsoft's sustainability goals and has positively impacted Constellation Energy's stock.

Portfolio Pulse from Ananya Gairola

September 24, 2024 | 4:04 am